Analysis of Polymer Nanoparticles in Blood Plasma by Nanoparticle tracking analysis (NTA) (CAT#: STEM-MB-0715-WXH)

Name: Analysis of Polymer Nanoparticles in Blood Plasma by Nanoparticle tracking analysis (NTA)
SKU: STEM-MB-0715-WXH
Rating: 5 (1 reviews)

Introduction

A successful drug delivery system must overcome complex biological barriers. For particles injected into the blood, one of the first and most critical barriers pertains to blood stability to circulate through the human body. To effectively design drug delivery vehicles, interactions between the particles and blood, as well as the aggregation behavior, must be understood. Particle size and aggregation in blood plasma can be analyzed using a commercially available nanoparticle tracking analysis (NTA) system.

Buy Now

Principle Applications Procedure Materials

Principle

Nanoparticle tracking analysis (NTA) is a method for visualizing and analyzing particles in liquids that relates the rate of Brownian motion to particle size. The rate of movement is related only to the viscosity and temperature of the liquid; it is not influenced by particle density or refractive index. NTA allows the determination of a size distribution profile of small particles with a diameter of approximately 10-1000 nanometers (nm) in liquid suspension.

Applications

NTA has been used by commercial, academic, and government laboratories working with nanoparticle toxicology, drug delivery, exosomes, microvesicles, bacterial membrane vesicles, and other small biological particles, virology and vaccine production, ecotoxicology, protein aggregation, orthopedic implants, inks and pigments, and nanobubbles.